TRANSVAC2, a success story!

Updated: Aug 23, 2019

The TRANSVAC2 success story has been published online on European Commission website.

© Kadmy, #94355258, 2018. source: via

To date, 80 % of all vaccines have been produced in Europe. TRANSVAC2 will create the network necessary to ensure Europe maintains and expands its international competitive edge.

This will be achieved by optimising the workflow for vaccine development through European universities, research institutes, innovative start-ups and large biomedical enterprises.

Read the full article on

#Europeancommision #Vaccineswork #EuropeResearch

This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement N° 730964.

Be the first to know about the upcoming application calls, follow European Vaccine Initiative on:

  • LinkedIn Social Icon
  • Twitter Social Icon
Subscribe to TRANSVAC´s Mailing list

© 2021 European Vaccine Initiative. Designed by European Vaccine Initiative